# LC Scaffold Closeout — Transition Review

**Work ID:** LC-SCAFFOLD-CLOSEOUT  
**Branch:** `scaffold/lc-scaffold-closeout-transition-review`  
**Date:** 2026-05-24  
**Agent:** healthiq-core-engine (Cursor, CONTENT sprint)  
**Controlling authority:** `HealthIQ_AI_core_scaffold_completion_definition_v1.md` §14

---

## 1. Executive verdict

**GO WITH CONDITIONS** — scaffold phase complete enough to begin KB-WAVE governed intelligence ingestion.

The seven compressed scaffold sprints are merged to `main`, the scaffold smoke pack is green, standing architecture and contributor documentation exist, Tier 1 SSOT metadata is complete, and deterministic guards cover the major scaffold-defining behaviours. Residual risks are documented, bounded, and acceptable for a narrow KB-WAVE-1 start **provided** the conditions in §8 and §11 are enforced.

This artefact supports the transition decision. It does **not** authorise KB-WAVE-1 execution, merge, or launch readiness — GPT and human approval remain required for the next prompt.

---

## 2. Git and merge state

Recorded at implementation preflight (2026-05-24):

| Check | Result | Evidence |
|-------|--------|----------|
| Current branch | `scaffold/lc-scaffold-closeout-transition-review` | `git branch --show-current` |
| `main` HEAD | `c377c9d` | `git rev-parse main` |
| `origin/main` HEAD | `c377c9d` | `git rev-parse origin/main` — **aligned** |
| Stash | Empty | `git stash list` — no entries |
| Work package token | Present | `automation_bus/state/work_package_active.json` — `LC-SCAFFOLD-CLOSEOUT` |

All seven compressed scaffold sprint implementation commits are present on `main` ancestry (see §3).

---

## 3. Scaffold sprint completion table

| Sprint | Status | Evidence | Residual risk |
|--------|--------|----------|---------------|
| **LC-S12B** — Core Scaffold Definition | **Merged** | `d3e313c` docs(LC-S12B); `df56273` kernel COMPLETE | Gate A approval record empty in `LC-S12B_core_scaffold_definition_notes.md` §7 — programme ran per explicit directive without formal three-party sign-off |
| **LC-S13** — Lifestyle Propagation | **Merged** | `9f68bc8` LC-S13 implementation; `906a9fc` kernel COMPLETE | Browser UAT not executed; renal/fasting bridges depend on questionnaire fields; Gate A still DRAFT |
| **LC-S14** — Direction-Aware Scoring | **Merged** | `0740a6e` feat(scoring); `8259a8a` kernel COMPLETE | GGT/ALP/ApoA1 system enrolment deferred; `bio_stats_engine` burden vectors may still treat low enzymes symmetrically |
| **LC-S16/17/19** — KB Surface + DTO Contract | **Merged** | `e44c189` feat(scaffold); `1cfa2c2` kernel COMPLETE | `package_estate_KB-S49_v1.yaml` stale vs ~109 on-disk packages; hero/body fallback chains remain frontend-derived |
| **LC-S18** — WHY Registration Generalisation | **Merged** | `e8c8310` feat(scaffold); `f5bb018` kernel COMPLETE | New targets still need loader row in `load_root_cause_hypotheses.py`; LC-S18A estate inventory refresh deferred |
| **LC-S20/22** — Persisted Replay + Sentinel Phase 2 | **Merged** | `5c9873c` feat(scaffold); `701fcfa` kernel COMPLETE | No Playwright render verification; no stale UI banner; regeneration path not implemented |
| **LC-S21/23/23B** — Orchestrator + Docs + SSOT | **Merged** | `265822e` implementation; `667c3a1` kernel COMPLETE | Derived-marker phase still monolithic in `run()`; Tier 2 metadata carry-forward; hybrid WHY registry needs manual `RootCauseTargetSpec` row |

**Answer to review Q1:** All seven compressed scaffold sprints are merged to `main`.  
**Answer to review Q2:** `main` and `origin/main` are aligned at `c377c9d`.

---

## 4. Scaffold smoke-pack results

Run during LC-SCAFFOLD-CLOSEOUT implementation (2026-05-24):

```powershell
python -m pytest backend/tests/regression/test_lc_s8f_phase_b_true_conversions.py -q
python -m pytest backend/tests/regression/test_lc_s8g_uploaded_unit_display_fidelity.py -q
python -m pytest backend/tests/regression/test_lc_s8d_unit_governance_sentinel.py -q
python -m pytest backend/tests/regression/test_lc_s10b_launch_core_protection.py -q
python -m pytest backend/tests/regression/test_lc_s11a_trust_blocker_correction.py -q
python -m pytest backend/tests/regression/test_lc_s13_lifestyle_coherence_narrative.py -q
python -m pytest backend/tests/regression/test_lc_s14_direction_aware_scoring.py -q
python -m pytest backend/tests/regression/test_lc_s16_17_19_kb_surface_payload_contract.py -q
python -m pytest backend/tests/regression/test_lc_s18_root_cause_why_registration.py -q
python -m pytest backend/tests/regression/test_lc_s20_22_persisted_replay_sentinel_phase2.py -q
python -m pytest backend/tests/regression/test_lc_s21_23_23b_orchestrator_docs_ssot.py -q
python -m pytest backend/tests/unit/test_scoring_rules.py -q
```

| Module | Result |
|--------|--------|
| LC-S8F phase B conversions | **PASS** |
| LC-S8G uploaded unit display fidelity | **PASS** |
| LC-S8D unit governance Sentinel | **PASS** |
| LC-S10B launch core protection | **PASS** |
| LC-S11A trust blocker correction | **PASS** |
| LC-S13 lifestyle coherence narrative | **PASS** |
| LC-S14 direction-aware scoring | **PASS** |
| LC-S16/17/19 KB surface + payload contract | **PASS** |
| LC-S18 root-cause WHY registration | **PASS** |
| LC-S20/22 persisted replay Sentinel Phase 2 | **PASS** |
| LC-S21/23/23B orchestrator docs SSOT | **PASS** |
| Unit scoring rules | **PASS** |

**Combined:** 188 tests collected and executed — **all PASS** (exit code 0).

No file name substitutions were required.

**Answer to review Q3:** All scaffold smoke guards passing.

---

## 5. What the scaffold now has

Per `HealthIQ_AI_core_scaffold_completion_definition_v1.md` §2 and sprint evidence:

| Capability | Status |
|------------|--------|
| Deterministic Layer B analytical engine | Proven on AB baseline; homocysteine lead intact (LC-S11A, LC-S10B guards) |
| Governed signal ingestion | `signal_evaluator` with lab-range semantics; Sentinel guards active |
| Governed root-cause / WHY pathway | Hybrid registry + validation (LC-S18); 41 targets in `ROOT_CAUSE_TARGET_SPECS`; fingerprint-stable migration |
| Safe biomarker canonicalisation | Alias registry; LC-S8D unit governance guards |
| Governed unit handling | UK/SI conversion rules; LC-S8F/G fidelity guards |
| Lab-derived reference range preservation | Enforced; no global default ranges in scoring path |
| Direction-aware biomarker scoring | Policy-driven framework (LC-S14); ALT hardcoded bypass removed |
| Questionnaire / lifestyle propagation | Consumer surface wired (LC-S13); coherence guards |
| Structured Layer B → Layer C DTO contract | Field classification and leakage guards (LC-S16/17/19) |
| Persisted-result replay compatibility | Hybrid stale-result policy Option C (LC-S20/22); 16 regression tests |
| Sentinel protection | Phase 1 + Phase 2 scaffold defect classes; escaped-defects pack expanded through LC-S21/23/23B |
| Knowledge Bus registration process | Lifecycle framework documented (LC-S17); validators for required files |
| Maintainable orchestration phases | Partial decomposition to `orchestrator_phases_v1.py` (LC-S21); fingerprint proven |
| SSOT Tier 1 metadata | 21 biomarkers complete (`ssot_tier1_metadata_contract_v1.py`) |
| Standing architecture and contributor docs | `HealthIQ_AI_runtime_architecture_map_v1.md` + 6 developer guides (LC-S23) |

---

## 6. What the scaffold still does not have

Explicitly **not** scaffold scope (per definition §3) but relevant to expectations:

| Gap | Classification |
|-----|----------------|
| Full WHY coverage for all signals/biomarkers | Missing knowledge asset — KB-WAVE work |
| All biomarkers fully interpreted on every panel | Clinical content backlog |
| Final frontend product design / commercial UX polish | Frontend presentation — post-scaffold |
| Gemini / LLM narrative on consumer paths | Out of scope until explicitly authorised |
| Medication interaction overlays | KB-WAVE-7 (deferred until lifestyle pattern proven) |
| Medical application grade A | Requires KB-WAVE population on completed scaffold |

**Within scaffold programme — still incomplete or partial:**

| Gap | Classification |
|-----|----------------|
| Gate A formal three-party approval record | Governance gap — process, not machinery |
| LC-S18A package estate inventory refresh | Governance gap — ~109 orphan packages vs KB-S49 inventory |
| Playwright render-level persisted replay verification | Governance gap — backend DTO smoke only |
| Derived-marker orchestrator phase extraction | Scaffold defect (low urgency) — monolithic block remains |
| Tier 2 SSOT metadata (glucose, insulin, cortisol, CK) | Carry-forward to KB-WAVE prep |
| GGT/ALP/ApoA1 direction-aware system enrolment | Deferred LC-S14 extension |
| Stale-result UI banner and regeneration path | Governance gap — policy documented, UI not wired |
| `bio_stats_engine` low-enzyme asymmetry | Known deferred issue — outside LC-S14 scoring scope |

---

## 7. Residual risks carried forward

| Risk | Source | Severity | KB-WAVE impact |
|------|--------|----------|----------------|
| Gate A approval record empty | LC-S12B notes §7 | Medium (process) | Does not block narrow KB-WAVE-1 if human approves transition |
| Orphan package drift (~109 vs inventory) | LC-S16/18 notes | Medium | Blocks metadata-driven WHY discovery until LC-S18A |
| No Playwright render verification | LC-S20/22 notes | Medium | Render-level regressions not machine-enforced |
| Hybrid WHY loader still requires code row per target | LC-S18 notes | Low–Medium | Each new WHY target needs registry row + loader entry |
| Derived-marker phase monolithic | LC-S21 notes | Low | Maintainability only; output fingerprint stable |
| Tier 2 metadata incomplete | LC-S23B notes | Low | KB-WAVE waves may need metadata before WHY authoring |
| Frontend fallback chains / hero derivation | LC-S16 notes | Medium | Presentation risk; not analytical drift |
| No stale UI banner | LC-S20/22 notes | Low | User may not know persisted result is stale |

**Answer to review Q4:** No sprint left an **unresolved transition blocker** in the smoke pack or kernel gate sense. Deferred items above are **known deferred issues** with documented mitigations — not silent failures.

**Answer to review Q5:** Residual risks are acceptable for KB-WAVE start **with conditions** (§8).

---

## 8. Transition decision

**Decision:** **GO WITH CONDITIONS**

**Rationale:** All seven compressed sprints are merged, guards are green, and the platform machinery defined in §2 of the scaffold completion definition is substantially in place. The programme objective — stop repairing scaffold architecture and begin governed intelligence ingestion — is met at the structural level. Remaining gaps are either (a) intentional KB-WAVE content work, (b) documented deferred scaffold polish, or (c) process sign-off items.

**Conditions for KB-WAVE authorisation:**

1. Human product owner explicitly approves transition (this document is evidence, not authority).
2. Gate A approval record should be backfilled or explicitly waived with documented rationale.
3. KB-WAVE-1 must be narrow — single theme, single domain — not broad expansion.
4. LC-S18A (package estate inventory refresh) should run early in KB-WAVE programme or as KB-WAVE-1 preflight if metadata-driven discovery is required.
5. Do not treat SSOT metadata as runtime interpretation authority unless explicitly wired.
6. Do not silently auto-load orphan Knowledge Bus packages.
7. Do not start frontend redesign, Gemini activation, or medication overlays in KB-WAVE-1.
8. Every KB-WAVE sprint must inherit Sentinel obligations and update standing docs when patterns change.

**Answer to review Q6:** The system is structurally ready for governed intelligence ingestion.

**Answer to review Q10:** No **separate scaffold sprint is strictly required** before KB-WAVE-1. **LC-S18A** (estate inventory refresh) is strongly recommended as the first KB-WAVE preflight or parallel lightweight governance task if WHY package discovery is in scope.

---

## 9. Recommended first KB-WAVE

**Recommended:** **KB-WAVE-1 — LDL / ApoB / lipid transport WHY expansion**

| Factor | Assessment |
|--------|------------|
| Commercial frequency | High — lipid panels are common |
| User recognisability | Strong — LDL/ApoB widely understood |
| Existing domain relevance | Cardiovascular signals and scoring already active |
| End-to-end path exercise | Exercises signal → WHY → DTO → frontend surfacing |
| SSOT readiness | LDL, HDL, ApoB, ApoA1, total cholesterol, triglycerides — Tier 1 metadata complete |
| Root-cause registry | Existing targets; expansion fits LC-S18 hybrid pattern |
| Sentinel / replay inheritance | Can extend persisted replay corpus with lipid-lead fixture |

**Alternative considered:** KB-WAVE-2 (thyroid) — equally viable but lower immediate commercial signal density on typical AB panels. Lipid transport WHY expansion is the better first proof of the KB-WAVE copy-edit-test-Sentinel loop.

**Answer to review Q7:** KB-WAVE-1 LDL / ApoB / lipid transport WHY expansion.

---

## 10. KB-WAVE rules inherited from scaffold phase

From `healthiq_scaffold_guardrails_v1.md`, scaffold definition §12–§13, and Automation Bus SOP:

1. **Automation Bus required** for any work touching `backend/core/`, `backend/ssot/`, `knowledge_bus/`, or analytical contracts.
2. **No fallback parsers** — canonical alias resolution only.
3. **Lab-derived ranges authoritative** — no global/default ranges where panel ranges exist.
4. **Frontend is renderer only** — no clinical inference in UI code.
5. **No hidden Gemini** in deterministic analytical path.
6. **No silent mutation** of historical persisted reports.
7. **No raw signal/internal IDs** in user-facing text.
8. **DTO changes require** frontend consumer trace, regression tests, and stale-result assessment.
9. **No unvalidated orphan package auto-loading.**
10. **Behaviour changes require** explicit `change_type: BEHAVIOUR | MIXED` and hardened prompt.
11. **Standing documentation obligation** — update architecture map and relevant developer guide when introducing new patterns.
12. **Scaffold smoke pack** must remain green; new KB-WAVE work adds regression targets, not replaces guards.
13. **Sentinel defect classes** must point to active deterministic tests — no placeholders.
14. **Identical input → identical output** — determinism preserved across KB-WAVE ingestion.

**Answer to review Q9:** Every KB-WAVE inherits the full guard suite (§4), plus sprint-specific regressions, Sentinel promotion for any escaped defect, Automation Bus lifecycle, and documentation update obligation.

---

## 11. Explicit no-go conditions for KB-WAVE-1

KB-WAVE-1 must **not**:

| Prohibition | Reason |
|-------------|--------|
| Frontend redesign or commercial UX overhaul | Scaffold contract still stabilising; presentation backlog is separate |
| Gemini / LLM narrative activation | Double-opt-in gate exists; not authorised |
| Broad multi-domain KB expansion | First wave must prove narrow ingestion loop |
| Medication interaction overlays | KB-WAVE-7 — deferred per strategic plan |
| Scoring policy or unit governance changes | Out of KB-WAVE-1 scope unless explicitly escalated |
| DTO restructuring | Requires frontend trace; not needed for WHY content addition |
| Runtime SSOT metadata interpretation wiring | Metadata supports authoring only until explicitly wired |
| Auto-loading orphan packages from disk scan | LC-S16/18 governance gap |
| Bypassing Sentinel or golden gate | Non-negotiable per SOP §15 |
| Skipping persisted replay / fingerprint check for output-touching changes | LC-S20/22 policy |

**Answer to review Q8:** See table above.

---

## 12. Recommended next prompt

Author a **KB-WAVE-1** Automation Bus work package:

```yaml
---
work_id: KB-WAVE-1-LDL-APOB
branch: kb-wave/kb-wave-1-ldl-apob-lipid-why
risk_level: HIGH
execution_model: TWO_PHASE_START_FINISH
change_type: MIXED
---
```

**Suggested scope:**

1. Governed WHY assets for LDL / ApoB / lipid transport signal family (Knowledge Bus content + registration).
2. Root-cause registry rows and loader entries for new targets (minimal BEHAVIOUR).
3. Regression fixtures proving signal → WHY → DTO surfacing for lipid-lead panel.
4. Sentinel defect classes for missing governed WHY when signal fires.
5. Optional: extend persisted replay corpus with lipid-lead fixture.
6. Documentation updates to `how_to_add_why_coverage_v1.md` if pattern changes.

**Preflight dependencies:**

- Run LC-S18A estate inventory refresh **or** explicitly scope WHY assets to inventory-listed packages only.
- Confirm Tier 1 lipid biomarker SSOT metadata sufficient for authoring (already complete per LC-S23B).
- Hardening must cross-reference schema, runtime evaluator, and source assets per SOP §2A.

**Do not include in KB-WAVE-1:** thyroid, iron, renal, cortisol, medication, sex hormones, liver enzyme patterns, frontend redesign, Gemini.

---

## Preflight record (mandatory)

```text
git branch --show-current
→ scaffold/lc-scaffold-closeout-transition-review

git status --short (at kernel start)
→ clean (after bus bootstrap commit 90160ba)

git log --oneline -n 12
→ 90160ba chore(bus): LC-SCAFFOLD-CLOSEOUT work package prompt and hardening
→ c377c9d docs(sop): clarify kernel status artefact closure policy
→ 667c3a1 chore(bus): LC-S21-23-23B kernel COMPLETE status
→ 265822e LC-S21/23/23B: orchestrator phases, scaffold docs, Tier 1 SSOT metadata.
→ … (full scaffold programme on ancestry)

git stash list
→ (empty)

Test-Path automation_bus/state/work_package_active.json
→ True (work_id LC-SCAFFOLD-CLOSEOUT, branch match confirmed)
```

---

## Cursor completion statement

Cursor produced documentation artefacts only (`docs/audit-papers/LC_SCAFFOLD_CLOSEOUT_transition_review.md`).

Cursor does **not** self-certify scaffold completion, KB-WAVE readiness, merge readiness, or permission to begin KB-WAVE-1. Human and GPT approval remain required.
